Brokerages Set Diversified Healthcare Trust (NASDAQ:DHC) Target Price at $4.92

Diversified Healthcare Trust (NASDAQ:DHCGet Rating) has been given an average rating of “Hold” by the six ratings firms that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $4.92.

A number of research firms have recently weighed in on DHC. B. Riley lowered their price target on Diversified Healthcare Trust from $6.00 to $5.00 in a report on Monday, May 9th. Zacks Investment Research cut Diversified Healthcare Trust from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 10th. StockNews.com initiated coverage on Diversified Healthcare Trust in a report on Thursday, March 31st. They set a “hold” rating for the company. Finally, TheStreet upgraded Diversified Healthcare Trust from a “d” rating to a “c-” rating in a report on Thursday, February 24th.

NASDAQ DHC opened at $2.20 on Friday. The stock has a market cap of $525.78 million, a PE ratio of 1.08, a P/E/G ratio of 1.46 and a beta of 1.53. The company has a current ratio of 2.00, a quick ratio of 2.00 and a debt-to-equity ratio of 0.99. Diversified Healthcare Trust has a twelve month low of $2.02 and a twelve month high of $4.34. The stock has a fifty day simple moving average of $2.71 and a 200-day simple moving average of $2.93.

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 19th. Investors of record on Monday, April 25th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 1.82%. The ex-dividend date is Friday, April 22nd. Diversified Healthcare Trust’s dividend payout ratio (DPR) is 1.97%.

A number of hedge funds have recently bought and sold shares of the business. Goldman Sachs Group Inc. raised its position in Diversified Healthcare Trust by 18.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 757,322 shares of the real estate investment trust’s stock valued at $2,423,000 after purchasing an additional 119,257 shares in the last quarter. Aristeia Capital LLC acquired a new stake in Diversified Healthcare Trust in the 1st quarter valued at about $2,122,000. State Street Corp raised its position in Diversified Healthcare Trust by 12.3% in the 1st quarter. State Street Corp now owns 15,659,509 shares of the real estate investment trust’s stock valued at $50,110,000 after purchasing an additional 1,710,824 shares in the last quarter. Invesco Ltd. raised its position in Diversified Healthcare Trust by 12.4% in the 1st quarter. Invesco Ltd. now owns 1,799,176 shares of the real estate investment trust’s stock valued at $5,757,000 after purchasing an additional 198,331 shares in the last quarter. Finally, Hsbc Holdings PLC raised its position in Diversified Healthcare Trust by 34.7% in the 1st quarter. Hsbc Holdings PLC now owns 116,371 shares of the real estate investment trust’s stock valued at $375,000 after purchasing an additional 30,009 shares in the last quarter. 82.08% of the stock is currently owned by institutional investors.

Diversified Healthcare Trust Company Profile (Get Rating)

DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc, an alternative asset management company that is headquartered in Newton, MA.

Recommended Stories

Receive News & Ratings for Diversified Healthcare Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diversified Healthcare Trust and related companies with MarketBeat.com's FREE daily email newsletter.